BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 622917 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCc1ccccc1 InChI=1S/C26H25NO4/c28-25(24(20-12-6-2-7-13-20)21-14-8-3-9-15-21)27-17-22(16-23(27)26(29)30)31-18-19-10-4-1-5-11-19/h1-15,22-24H,16-18H2,(H,29,30) BFTWTVUNMXYGBN-UHFFFAOYSA-N 318742 (2S,4S)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 2::US10370388, Compound 2 Type-2 angiotensin II receptor Human 114 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318742 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318742&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677468 384222031 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622918 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCc1ccccc1 InChI=1S/C26H25NO4/c28-25(24(20-12-6-2-7-13-20)21-14-8-3-9-15-21)27-17-22(16-23(27)26(29)30)31-18-19-10-4-1-5-11-19/h1-15,22-24H,16-18H2,(H,29,30) BFTWTVUNMXYGBN-UHFFFAOYSA-N 318743 (2S,4R)-4-(benzyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 3::US10370388, Compound 3 Type-2 angiotensin II receptor Human 193 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318743 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318743&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677779 384222032 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622919 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCC=Cc1ccccc1 |w:25.27| InChI=1S/C28H27NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-17,24-26H,18-20H2,(H,31,32) XDYXKVYDCSLVKA-UHFFFAOYSA-N 318744 (2S,4S)-4-cinnamyloxy-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 5::US10370388, Compound 5 Type-2 angiotensin II receptor Human 90.0 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318744 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318744&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681564 384222033 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622920 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 |r| InChI=1S/C28H29NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32) OSURWJVNFXMFKH-UHFFFAOYSA-N 318745 Compound 9 (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxylic acid::US9624243, 6::US10370388, Compound 6 Type-2 angiotensin II receptor Human 181 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318745 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318745&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71604416 384222034 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622921 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C28H29NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32) OSURWJVNFXMFKH-UHFFFAOYSA-N 318746 (2S,4R)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxylic acid::US9624243, 9::US10370388, Compound 9 Type-2 angiotensin II receptor Human 98.6 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318746 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318746&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681480 384222035 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622922 OC(C(c1ccccc1)c1ccccc1)N1C(Cc2c1cccc2Oc1ccccc1)C(O)=O InChI=1S/C29H25NO4/c31-28(27(20-11-4-1-5-12-20)21-13-6-2-7-14-21)30-24-17-10-18-26(23(24)19-25(30)29(32)33)34-22-15-8-3-9-16-22/h1-18,25,27-28,31H,19H2,(H,32,33) MQFNNVIKXNUVOZ-UHFFFAOYSA-N 318747 4-(benzyloxy)-1-(2,2-diphenylacetyl)indoline-2-carboxlic acid::US9624243, 15 Type-2 angiotensin II receptor Human 54.5 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318747 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318747&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374609 384222036 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622923 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OC[C@@H]1C[C@H]1c1ccccc1 InChI=1S/C29H29NO4/c31-28(27(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-18-24(17-26(30)29(32)33)34-19-23-16-25(23)20-10-4-1-5-11-20/h1-15,23-27H,16-19H2,(H,32,33) CYMXHUCDSZNIGX-UHFFFAOYSA-N 318748 (2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2R)-2-phenylcyclopropyl)methoxy)pyrrolidine-2-carboxylic ::US9624243, 16::US10370388, Compound 16 Type-2 angiotensin II receptor Human 6654 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318748 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318748&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117776871 384222037 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622924 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OC[C@@H]1C[C@@H]1c1ccccc1 InChI=1S/C29H29NO4/c31-28(27(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-18-24(17-26(30)29(32)33)34-19-23-16-25(23)20-10-4-1-5-11-20/h1-15,23-27H,16-19H2,(H,32,33) CYMXHUCDSZNIGX-UHFFFAOYSA-N 318749 (2S,4S)-1-(2,2-diphenylacetyl)-4-(((1R,2S)-2-phenylcyclopropyl)methoxy)pyrrolidine-2-carboxylic acid ::US9624243, 17::US10370388, Compound 17 Type-2 angiotensin II receptor Human 3974 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318749 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318749&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681518 384222038 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622925 CN(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H32N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34) IODJNDRBUIMETF-UHFFFAOYSA-N 318750 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 21::US10370388, Compound 21 Type-2 angiotensin II receptor Human 62.1 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318750 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318750&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677556 384222039 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622926 CN(CCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C28H30N2O3/c1-29(18-17-21-11-5-2-6-12-21)24-19-25(28(32)33)30(20-24)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26H,17-20H2,1H3,(H,32,33) QPRNQNJCPFYMHW-UHFFFAOYSA-N 318751 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(phenylethylamino)pyrrolidine-2-carboxylic acid::US9624243, 22::US10370388, Compound 22 Type-2 angiotensin II receptor Human 384 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318751 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318751&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681622 384222040 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622927 OC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCN(CC1)c1ccccc1 InChI=1S/C29H31N3O3/c33-28(27(22-10-4-1-5-11-22)23-12-6-2-7-13-23)32-21-25(20-26(32)29(34)35)31-18-16-30(17-19-31)24-14-8-3-9-15-24/h1-15,25-27H,16-21H2,(H,34,35) XYLRMVKCCBZNNZ-UHFFFAOYSA-N 318752 (2S,4S)-1-(2,2-diphenylacetyl)-4-(4-phenylpiperazine)pyrrolidine-2-carboxylic acid::US9624243, 23 Type-2 angiotensin II receptor Human 290 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318752 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318752&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374610 384222041 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622928 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCOC[C@@H]1Cc1ccccc1 InChI=1S/C30H32N2O4/c33-29(28(23-12-6-2-7-13-23)24-14-8-3-9-15-24)32-20-25(19-27(32)30(34)35)31-16-17-36-21-26(31)18-22-10-4-1-5-11-22/h1-15,25-28H,16-21H2,(H,34,35) TVDXVKSOROZAFV-UHFFFAOYSA-N 318753 (2S,4S)-4-((S)-3-benzylmorpholino)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 28::US10370388, Compound 28 Type-2 angiotensin II receptor Human 86.9 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318753 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318753&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681525 384222042 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622929 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NC(=O)CCc1ccccc1 |r| InChI=1S/C28H28N2O4/c31-25(17-16-20-10-4-1-5-11-20)29-23-18-24(28(33)34)30(19-23)27(32)26(21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-15,23-24,26H,16-19H2,(H,29,31)(H,33,34) MOWSLAHDBCUMSN-UHFFFAOYSA-N 318754 Compound 96 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylpropanamido)-pyrrolidine-2-carboxylic acid::US9624243, 35::US10370388, Compound 96 Type-2 angiotensin II receptor Human 540 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318754 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318754&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681631 384222043 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622930 CN([C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O)C(=O)CCc1ccccc1 |r| InChI=1S/C29H30N2O4/c1-30(26(32)18-17-21-11-5-2-6-12-21)24-19-25(29(34)35)31(20-24)28(33)27(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-25,27H,17-20H2,1H3,(H,34,35) YAHHFSHBEGPKKO-UHFFFAOYSA-N 318755 Compound 97 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-methyl-3-phenylpropanamido)pyrrolidine-2-carboxylic acid::US9624243, 36 Type-2 angiotensin II receptor Human 1664 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318755 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318755&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762654 384222044 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622931 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NCCc1ccccc1 InChI=1S/C27H28N2O3/c30-26(25(21-12-6-2-7-13-21)22-14-8-3-9-15-22)29-19-23(18-24(29)27(31)32)28-17-16-20-10-4-1-5-11-20/h1-15,23-25,28H,16-19H2,(H,31,32) VMLXSXJSLHISBZ-UHFFFAOYSA-N 318756 (2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylamino)-pyrrolidine-2-carboxylic acid::US9624243, 46::US10370388, Compound 46 Type-2 angiotensin II receptor Human 2257 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318756 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318756&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677614 384222045 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622932 OC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)c1sccc1-c1ccccc1 |r| InChI=1S/C29H25NO3S/c31-28(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-19-23(18-25(30)29(32)33)27-24(16-17-34-27)20-10-4-1-5-11-20/h1-17,23,25-26H,18-19H2,(H,32,33) LFNOXHBHIFQLEL-UHFFFAOYSA-N 318757 Compound 107 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-yl)-pyrrolidine-2-carboxylic acid::US9624243, 48 Type-2 angiotensin II receptor Human 89.4 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318757 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318757&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788400 384222046 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622933 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35) NLEUYIKWYGKLNG-UHFFFAOYSA-N 318758 (2S,4S)-1-(2,2-diphenylacetyl)-4-((R)-3-phenylpiperidin-1-yl)pyrrolidine-2-carboxylic acid::US9624243, 49::US10370388, Compound 49 Type-2 angiotensin II receptor Human 58.8 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318758 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318758&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762386 384222047 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622934 CN(C)S(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 |r| InChI=1S/C30H35N3O5S/c1-32(2)39(36,37)31-29(34)27-21-26(38-20-12-15-23-13-6-3-7-14-23)22-33(27)30(35)28(24-16-8-4-9-17-24)25-18-10-5-11-19-25/h3-11,13-14,16-19,26-28H,12,15,20-22H2,1-2H3,(H,31,34) NPFUOBKNVTUWIO-UHFFFAOYSA-N 318759 (2S,4S)—N—(N,N-dimethylsulfamoyl)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxamide::US9624243, 50::US10370388, Compound 112 Type-2 angiotensin II receptor Human 67.3 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318759 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318759&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762099 384222048 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622935 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35) NLEUYIKWYGKLNG-UHFFFAOYSA-N 318760 US9624243, 51::US10370388, Compound 50 Type-2 angiotensin II receptor Human 50.3 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318760 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318760&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374611 384222049 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622936 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCC(Cc2ccccc2)C1 InChI=1S/C31H34N2O3/c34-30(29(25-14-6-2-7-15-25)26-16-8-3-9-17-26)33-22-27(20-28(33)31(35)36)32-18-10-13-24(21-32)19-23-11-4-1-5-12-23/h1-9,11-12,14-17,24,27-29H,10,13,18-22H2,(H,35,36) ONGGULVSDDXGNW-UHFFFAOYSA-N 318761 (2S,4S)-4-(3-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US9624243, 53::US10370388, Compound 53 Type-2 angiotensin II receptor Human 43.9 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318761 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318761&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677777 384222050 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622937 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)Oc1ccccc1 |r| InChI=1S/C25H23NO4/c27-24(23(18-10-4-1-5-11-18)19-12-6-2-7-13-19)26-17-21(16-22(26)25(28)29)30-20-14-8-3-9-15-20/h1-15,21-23H,16-17H2,(H,28,29) JYVNYAQCWNLRLM-UHFFFAOYSA-N 318762 (28,48)-4-((benzyloxymethyl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 54 Type-2 angiotensin II receptor Human 155 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318762 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318762&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374612 384222051 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622938 OC(=O)[C@@H]1C[C@H](CCOCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C28H29NO4/c30-27(26(23-12-6-2-7-13-23)24-14-8-3-9-15-24)29-19-22(18-25(29)28(31)32)16-17-33-20-21-10-4-1-5-11-21/h1-15,22,25-26H,16-20H2,(H,31,32) HOCFJOJMTFGJRJ-UHFFFAOYSA-N 318763 (2S,4R)-4-(2-(benzyloxy)ethyl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US9624243, 55::US10370388, Compound 55 Type-2 angiotensin II receptor Human 386 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318763 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318763&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677689 384222052 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622939 OC(=O)[C@H]1[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 |r| InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31) YVHCQCFELZHKAG-UHFFFAOYSA-N 318764 1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone and 14(2S,3R)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US9624243, 56::US10370388, Compound 143 Type-2 angiotensin II receptor Human 316 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318764 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318764&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677758 384222053 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622940 OC(=O)[C@H]1[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 |r| InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31) YVHCQCFELZHKAG-UHFFFAOYSA-N 318765 (2R,3R)-3-(3-phenylpropoxy)-1-(2,2-diphenylacetyl)-azetidine-2-carboxylic acid and (2S,3S)-3-(3-phenylpropoxy)-1-(2,2-diphenylacetyl)-azetidine-2-carboxylic acid::US9624243, 58 Type-2 angiotensin II receptor Human 3050 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318765 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318765&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788401 384222054 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622941 OC(=O)[C@@H]1C[C@@H](CN1)N1CCCC1(Cc1ccccc1)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C30H32N2O3/c33-28(27(23-13-6-2-7-14-23)24-15-8-3-9-16-24)30(20-22-11-4-1-5-12-22)17-10-18-32(30)25-19-26(29(34)35)31-21-25/h1-9,11-16,25-27,31H,10,17-21H2,(H,34,35) WOYZQVSEOIHVEM-UHFFFAOYSA-N 318766 (3′S,5′S)-2-benzyl-(2,2-diphenylacetyl)-[1,3′-bipyrrolidine]-5′-carboxylic acid::US9624243, 61-A Type-2 angiotensin II receptor Human 83.3 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318766 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318766&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374613 384222055 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622942 OC(=O)[C@H]1C[C@H](CN1)N1CCCC1(Cc1ccccc1)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C30H32N2O3/c33-28(27(23-13-6-2-7-14-23)24-15-8-3-9-16-24)30(20-22-11-4-1-5-12-22)17-10-18-32(30)25-19-26(29(34)35)31-21-25/h1-9,11-16,25-27,31H,10,17-21H2,(H,34,35) WOYZQVSEOIHVEM-UHFFFAOYSA-N 318767 (3′R,5′R)-2-benzyl-(2,2-diphenylacetyl)-[1,3′-bipyrrolidine]-5′-carboxylic acid::US9624243, 61-B Type-2 angiotensin II receptor Human 107 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318767 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318767&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374614 384222056 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622943 CN(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(C1CCCCC1)c1ccccc1)C(O)=O InChI=1S/C29H38N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-3,5-8,12-13,15-16,24-27H,4,9-11,14,17-21H2,1H3,(H,33,34) BAXNDSAXEQPGMO-UHFFFAOYSA-N 318768 (2S,4S)-1-(2-cyclohexyl-2-phenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 62::US10370388, Compound 62 Type-2 angiotensin II receptor Human 540 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318768 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318768&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681553 384222057 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622944 CN(CC1CC1c1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H32N2O3/c1-31(19-24-17-26(24)21-11-5-2-6-12-21)25-18-27(30(34)35)32(20-25)29(33)28(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-28H,17-20H2,1H3,(H,34,35) JKDRZXQFDUPUTM-UHFFFAOYSA-N 318769 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl((2-phenylcyclopropyl)methyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 63::US10370388, Compound 63 Type-2 angiotensin II receptor Human 483 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318769 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318769&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762404 384222058 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622945 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NC(=O)N(c1ccccc1)c1ccccc1 InChI=1S/C32H29N3O4/c36-30(29(23-13-5-1-6-14-23)24-15-7-2-8-16-24)34-22-25(21-28(34)31(37)38)33-32(39)35(26-17-9-3-10-18-26)27-19-11-4-12-20-27/h1-20,25,28-29H,21-22H2,(H,33,39)(H,37,38) ZRVCPEWFXXPDLS-UHFFFAOYSA-N 318770 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3,3-diphenyluriedo)-pyrrolidine-2-carboxylic acid::US9624243, 64 Type-2 angiotensin II receptor Human 3358 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318770 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318770&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788377 384222059 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622946 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(CNC(=O)C2c2ccccc2)CC1 InChI=1S/C33H35N3O4/c37-30-29(25-14-8-3-9-15-25)33(22-34-30)16-18-35(19-17-33)26-20-27(32(39)40)36(21-26)31(38)28(23-10-4-1-5-11-23)24-12-6-2-7-13-24/h1-15,26-29H,16-22H2,(H,34,37)(H,39,40) CCKVWWYAVWGVAZ-UHFFFAOYSA-N 318771 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-oxo-4-phenyl-2,8-diazaspiro[4,5]decan-8-yl)pyrrolidine-2-carboxylic acid::US9624243, 65::US10370388, Compound 65 Type-2 angiotensin II receptor Human 1605 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318771 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318771&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117763309 384222060 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622947 CN(CCCc1ccccc1)[C@@H]1CN(C[C@H]1C(O)=O)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H32N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)26-21-31(20-25(26)29(33)34)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34) BSDYLUQKLPPVEB-UHFFFAOYSA-N 318772 (3R,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylpropyl)amino)pyrrolidine-3-carboxylic acid::US9624243, 67::US10370388, Compound 67 Type-2 angiotensin II receptor Human 3665 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318772 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318772&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117761783 384222061 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622948 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCCC1Cc1ccccc1 InChI=1S/C31H34N2O3/c34-30(29(24-14-6-2-7-15-24)25-16-8-3-9-17-25)33-22-27(21-28(33)31(35)36)32-19-11-10-18-26(32)20-23-12-4-1-5-13-23/h1-9,12-17,26-29H,10-11,18-22H2,(H,35,36) GMIXLHJQCQOBDJ-UHFFFAOYSA-N 318773 (2S,4S)-4-(2-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US9624243, 70-B::US10370388, Compound 70-A Type-2 angiotensin II receptor Human 1340 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318773 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318773&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681537 384222062 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622949 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCCCC1Cc1ccccc1 InChI=1S/C31H34N2O3/c34-30(29(24-14-6-2-7-15-24)25-16-8-3-9-17-25)33-22-27(21-28(33)31(35)36)32-19-11-10-18-26(32)20-23-12-4-1-5-13-23/h1-9,12-17,26-29H,10-11,18-22H2,(H,35,36) GMIXLHJQCQOBDJ-UHFFFAOYSA-N 318774 (2R,4R)-4-(2-benzylpiperidin-1-yl)-1-(2,2-diphenylacetyl)-pyrrolidine-2-carboxylic acid::US9624243, 70-A::US10370388, Compound 70-B Type-2 angiotensin II receptor Human 49.1 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318774 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318774&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374615 384222063 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622950 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(CC1)C(NC2=O)c1ccccc1 InChI=1S/C32H33N3O4/c36-29(27(22-10-4-1-5-11-22)23-12-6-2-7-13-23)35-21-25(20-26(35)30(37)38)34-18-16-32(17-19-34)28(33-31(32)39)24-14-8-3-9-15-24/h1-15,25-28H,16-21H2,(H,33,39)(H,37,38) DFXQPZOFUMNKEM-UHFFFAOYSA-N 318775 (2S,4S)-1-(2,2-diphenylacetyl)-4-(1-oxo-3-phenyl-2,7-diazaspiro[3,5]nonan-7-yl)pyrrolidine-2-carboxylic acid::US9624243, 75::US10370388, Compound 75 Type-2 angiotensin II receptor Human 3829 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318775 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318775&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681593 384222064 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622951 CN(C)S(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N(C)CCCc1ccc(F)cc1 |r| InChI=1S/C31H37FN4O4S/c1-34(2)41(39,40)33-30(37)28-21-27(35(3)20-10-11-23-16-18-26(32)19-17-23)22-36(28)31(38)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-19,27-29H,10-11,20-22H2,1-3H3,(H,33,37) UDXHQRMQQJQHMN-UHFFFAOYSA-N 318776 (2S,4S)-(N,N-dimethylsulfamoyl)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 76 Type-2 angiotensin II receptor Human 3604 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318776 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318776&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117788419 384222065 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622952 COC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@H]2CN(C[C@@H]12)c1ccccc1 |r| InChI=1S/C33H37N3O3/c1-39-33(38)29-20-28(35-19-11-16-26-21-34(23-30(26)35)27-17-9-4-10-18-27)22-36(29)32(37)31(24-12-5-2-6-13-24)25-14-7-3-8-15-25/h2-10,12-15,17-18,26,28-31H,11,16,19-23H2,1H3 XKQFTBHOSCAIIQ-UHFFFAOYSA-N 318777 (2S,4S)-44(4aS,7aS)-6-benzoctahydro-1H-pyrrolo[3,4-b]pyridin-1-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 84 Type-2 angiotensin II receptor Human 75.8 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318777 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318777&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374616 384222066 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622953 COC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@@H]2CN(C[C@H]12)c1ccccc1 |r| InChI=1S/C33H37N3O3/c1-39-33(38)29-20-28(35-19-11-16-26-21-34(23-30(26)35)27-17-9-4-10-18-27)22-36(29)32(37)31(24-12-5-2-6-13-24)25-14-7-3-8-15-25/h2-10,12-15,17-18,26,28-31H,11,16,19-23H2,1H3 XKQFTBHOSCAIIQ-UHFFFAOYSA-N 318778 (2S,4S)-4-((4aR,7aR)-6-benzoctahydro-1H-pyrrolo[3,4-b]-pyridin-1-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 85 Type-2 angiotensin II receptor Human 103 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318778 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318778&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374617 384222067 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622954 COC(=O)[C@@H]1CC(CN1C(=O)C(c1ccccc1)c1ccccc1)N1CC[C@H](C1)c1ccccc1 |r| InChI=1S/C30H32N2O3/c1-35-30(34)27-19-26(31-18-17-25(20-31)22-11-5-2-6-12-22)21-32(27)29(33)28(23-13-7-3-8-14-23)24-15-9-4-10-16-24/h2-16,25-28H,17-21H2,1H3 DZNDUXZXJHZLIW-UHFFFAOYSA-N 318779 (3S,3′S,5′S)-1-(2,2-diphenylacetyl)-3-(phenyl-[1,3′-bipyrrolidine]-5′-carboxylic acid::US9624243, 86 Type-2 angiotensin II receptor Human 817 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318779 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318779&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374618 384222068 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622955 OC(=O)[C@@H]1CC(CC1C(=C)C(c1ccccc1)c1ccccc1)N1CC[C@@H](C1)c1ccccc1 |r| InChI=1S/C31H33NO2/c1-22(30(24-13-7-3-8-14-24)25-15-9-4-10-16-25)28-19-27(20-29(28)31(33)34)32-18-17-26(21-32)23-11-5-2-6-12-23/h2-16,26-30H,1,17-21H2,(H,33,34) MFHCOBYOZAKINK-UHFFFAOYSA-N 318780 (3R,3′S,5′S)-1-(2,2-diphenylacetyl)-3-(phenyl-[1,3′-bipyrrolidine]-5′-carboxylic acid::US9624243, 87 Type-2 angiotensin II receptor Human 43.6 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318780 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318780&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374619 384222069 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622956 CN(CCCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H34N2O3/c1-31(20-12-11-15-23-13-5-2-6-14-23)26-21-27(30(34)35)32(22-26)29(33)28(24-16-7-3-8-17-24)25-18-9-4-10-19-25/h2-10,13-14,16-19,26-28H,11-12,15,20-22H2,1H3,(H,34,35) BFGDVADCTRJNRK-UHFFFAOYSA-N 318781 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(4-phenylbutyl)-amino)pyrrolidine-2-carboxylic acid::US9624243, 90::US10370388, Compound 90 Type-2 angiotensin II receptor Human 64.2 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318781 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318781&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681591 384222070 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622957 CN(CCCc1ccc(F)cc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H31FN2O3/c1-31(18-8-9-21-14-16-24(30)17-15-21)25-19-26(29(34)35)32(20-25)28(33)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H,34,35) KMGJCWPNNFAXPR-UHFFFAOYSA-N 318782 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophenyl)-propyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 91::US10370388, Compound 91 Type-2 angiotensin II receptor Human 12.0 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318782 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318782&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677805 384222071 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622958 COc1ccc(CCCN(C)[C@H]2C[C@H](N(C2)C(=O)C(c2ccccc2)c2ccccc2)C(O)=O)cc1C InChI=1S/C31H36N2O4/c1-22-19-23(16-17-28(22)37-3)11-10-18-32(2)26-20-27(31(35)36)33(21-26)30(34)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-17,19,26-27,29H,10-11,18,20-21H2,1-3H3,(H,35,36) LLQSSPNKGGGVDA-UHFFFAOYSA-N 318783 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-methylphenyl)propyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 92::US10370388, Compound 92 Type-2 angiotensin II receptor Human 134 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318783 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318783&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681600 384222072 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622959 CC(CCN[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O)c1cccnc1 InChI=1S/C28H31N3O3/c1-20(23-13-8-15-29-18-23)14-16-30-24-17-25(28(33)34)31(19-24)27(32)26(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-13,15,18,20,24-26,30H,14,16-17,19H2,1H3,(H,33,34) FHWGVVZIYMGQNR-UHFFFAOYSA-N 318784 (2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-pyridinyl)-propyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 93::US10370388, Compound 93 Type-2 angiotensin II receptor Human 126 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318784 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318784&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374620 384222073 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622960 OC(=O)[C@@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCC=Cc1ccccc1 |w:25.27| InChI=1S/C28H27NO4/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-17,24-26H,18-20H2,(H,31,32) XDYXKVYDCSLVKA-UHFFFAOYSA-N 318785 (2S,4R)-4-(cinnamyloxy)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 8::US10370388, Compound 8 Type-2 angiotensin II receptor Human 512 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318785 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318785&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374621 384222074 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622961 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)NC(=O)CCc1ccccc1 InChI=1S/C28H28N2O4/c31-25(17-16-20-10-4-1-5-11-20)29-23-18-24(28(33)34)30(19-23)27(32)26(21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-15,23-24,26H,16-19H2,(H,29,31)(H,33,34) MOWSLAHDBCUMSN-UHFFFAOYSA-N 318786 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylpropanamido)-pyrrolidine-2-carboxylic acid::US9624243, 96 Type-2 angiotensin II receptor Human 2248 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318786 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318786&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681631 384222075 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622962 CN([C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O)C(=O)CCc1ccccc1 InChI=1S/C29H30N2O4/c1-30(26(32)18-17-21-11-5-2-6-12-21)24-19-25(29(34)35)31(20-24)28(33)27(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-25,27H,17-20H2,1H3,(H,34,35) YAHHFSHBEGPKKO-UHFFFAOYSA-N 318787 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-methyl-3-phenylpropanamido)pyrrolidine-2-carboxylic acid::US9624243, 97::US10370388, Compound 97 Type-2 angiotensin II receptor Human 458 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318787 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318787&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762654 384222076 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622963 CC(=O)N(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C30H32N2O4/c1-22(33)31(19-11-14-23-12-5-2-6-13-23)26-20-27(30(35)36)32(21-26)29(34)28(24-15-7-3-8-16-24)25-17-9-4-10-18-25/h2-10,12-13,15-18,26-28H,11,14,19-21H2,1H3,(H,35,36) UCMHKXKUZOWWNT-UHFFFAOYSA-N 318788 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-3-phenylpropyl)-acetamido)pyrrolidine-2-carboxylic acid::US9624243, 98::US10370388, Compound 98 Type-2 angiotensin II receptor Human 240 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318788 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318788&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681498 384222077 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622964 CS(=O)(=O)N(CCCc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H32N2O5S/c1-37(35,36)31(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)30(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,33,34) IMTGAFVXLONOEN-UHFFFAOYSA-N 318789 (2S,4S)-1-(2,2-diphenylacetyl)-4-(N-(3-phenylpropyl)-methylsulfonamido)pyrrolidine-2-carboxylic acid::US9624243, 99::US10370388, Compound 99 Type-2 angiotensin II receptor Human 536 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318789 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318789&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677117 384222078 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622965 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)n1nncc1-c1ccccc1 InChI=1S/C27H24N4O3/c32-26(25(20-12-6-2-7-13-20)21-14-8-3-9-15-21)30-18-22(16-23(30)27(33)34)31-24(17-28-29-31)19-10-4-1-5-11-19/h1-15,17,22-23,25H,16,18H2,(H,33,34) WRAIPUGPFSGITD-UHFFFAOYSA-N 318790 (2S,4S)-1-(2,2-diphenylacetyl)-4-(5-phenyl-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxylic acid::US9624243, 100::US10370388, Compound 100 Type-2 angiotensin II receptor Human 18.0 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318790 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318790&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681500 384222079 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622966 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)n1nncc1Cc1ccccc1 InChI=1S/C28H26N4O3/c33-27(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)31-19-24(17-25(31)28(34)35)32-23(18-29-30-32)16-20-10-4-1-5-11-20/h1-15,18,24-26H,16-17,19H2,(H,34,35) HBTISMUQTHYNOL-UHFFFAOYSA-N 318791 (2S,4S)-4-(5-benzyl-1H-1,2,3-triazol-1-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US9624243, 101::US10370388, Compound 101 Type-2 angiotensin II receptor Human 400 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318791 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318791&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677531 384222080 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622967 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1[C@@H](Cc2ccccc2)COCC1=O InChI=1S/C30H30N2O5/c33-27-20-37-19-25(16-21-10-4-1-5-11-21)32(27)24-17-26(30(35)36)31(18-24)29(34)28(22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-15,24-26,28H,16-20H2,(H,35,36) OJWXNJCKTXACCI-UHFFFAOYSA-N 318792 (2S,4S)-4-((S)-3-benzyl-5-oxomorpholino)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic ::US9624243, 102::US10370388, Compound 102 Type-2 angiotensin II receptor Human 499 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318792 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318792&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622464 384222081 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622968 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccc(F)cc1 InChI=1S/C28H28FNO4/c29-23-15-13-20(14-16-23)8-7-17-34-24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33) GMJPSKAGKFLTFK-UHFFFAOYSA-N 318793 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-(4-fluorophenyl)-propoxy)pyrrolidine-2-carboxylic acid::US9624243, 104::US10370388, Compound 104 Type-2 angiotensin II receptor Human 1316 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318793 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318793&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677514 384222082 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622969 COc1ccc(cc1C)C#CCN(C)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C31H32N2O4/c1-22-19-23(16-17-28(22)37-3)11-10-18-32(2)26-20-27(31(35)36)33(21-26)30(34)29(24-12-6-4-7-13-24)25-14-8-5-9-15-25/h4-9,12-17,19,26-27,29H,18,20-21H2,1-3H3,(H,35,36) ZLCKDXQPZWPTJX-UHFFFAOYSA-N 318794 (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-methoxy-3-methylphenyl)prop-2-yn-1-yl)(methyl)amino)pyrrolidine-2-carboxylic acid::US9624243, 105::US10370388, Compound 105 Type-2 angiotensin II receptor Human 2489 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318794 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318794&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622463 384222083 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622970 OC(=O)[C@@H]1C[C@H](CCCCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H31NO3/c31-28(27(24-16-6-2-7-17-24)25-18-8-3-9-19-25)30-21-23(20-26(30)29(32)33)15-11-10-14-22-12-4-1-5-13-22/h1-9,12-13,16-19,23,26-27H,10-11,14-15,20-21H2,(H,32,33) AOXCIYMWJSEDFC-UHFFFAOYSA-N 318795 (2S,4S)-1-(2,2-diphenylacetyl)-4-(4-phenylbutyl)-pyrrolidine-2-carboxylic acid::US9624243, 106::US10370388, Compound 106 Type-2 angiotensin II receptor Human 426 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318795 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318795&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681611 384222084 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622971 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)c1sccc1-c1ccccc1 InChI=1S/C29H25NO3S/c31-28(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-19-23(18-25(30)29(32)33)27-24(16-17-34-27)20-10-4-1-5-11-20/h1-17,23,25-26H,18-19H2,(H,32,33) LFNOXHBHIFQLEL-UHFFFAOYSA-N 318796 (2S,4S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-yl)-pyrrolidine-2-carboxylic acid::US9624243, 107::US10370388, Compound 107 Type-2 angiotensin II receptor Human 461 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318796 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318796&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677817 384222085 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622972 OC[C@@H]1[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H29NO3/c29-20-24-25(31-18-10-13-21-11-4-1-5-12-21)19-28(24)27(30)26(22-14-6-2-7-15-22)23-16-8-3-9-17-23/h1-9,11-12,14-17,24-26,29H,10,13,18-20H2 YFRCJLYBFGAYRN-UHFFFAOYSA-N 318797 US9624243, 108::1-((2R,3S)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US10370388, Compound 108 Type-2 angiotensin II receptor Human 2054 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318797 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318797&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762289 384222086 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622973 OC[C@@H]1[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H29NO3/c29-20-24-25(31-18-10-13-21-11-4-1-5-12-21)19-28(24)27(30)26(22-14-6-2-7-15-22)23-16-8-3-9-17-23/h1-9,11-12,14-17,24-26,29H,10,13,18-20H2 YFRCJLYBFGAYRN-UHFFFAOYSA-N 318798 US9624243, 109::(1-((2R,3R)-2-(hydroxymethyl)-3-(3-phenylpropoxy)-azetidin-1-yl)-2,2-diphenylethanone::US10370388, Compound 109 Type-2 angiotensin II receptor Human 650 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318798 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318798&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677667 384222087 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622974 CN(C)S(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C30H35N3O5S/c1-32(2)39(36,37)31-29(34)27-21-26(38-20-12-15-23-13-6-3-7-14-23)22-33(27)30(35)28(24-16-8-4-9-17-24)25-18-10-5-11-19-25/h3-11,13-14,16-19,26-28H,12,15,20-22H2,1-2H3,(H,31,34) NPFUOBKNVTUWIO-UHFFFAOYSA-N 318799 US9624243, 112::(2S,4S)-N-(N,N-dimethylsulfamoyl)-1-(2,2-diphenylacetyl)-4-(3-phenylpropoxy)pyrrolidine-2-carboxamide Type-2 angiotensin II receptor Human 255 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318799 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318799&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762099 384222088 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622975 CN(C)S(=O)(=O)NC(=C)[C@@H]1C[C@@H](CC1C(=O)C(c1ccccc1)c1ccccc1)N(C)CCCc1ccc(F)cc1 |r| InChI=1S/C33H40FN3O3S/c1-24(35-41(39,40)36(2)3)30-22-29(37(4)21-11-12-25-17-19-28(34)20-18-25)23-31(30)33(38)32(26-13-7-5-8-14-26)27-15-9-6-10-16-27/h5-10,13-20,29-32,35H,1,11-12,21-23H2,2-4H3 MDWWIRKBZJZHEP-UHFFFAOYSA-N 318800 US9624243, 114::(2S,4S)-N-(N,N-dimethylsulfamoyl)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carboxylic acid Type-2 angiotensin II receptor Human 17.1 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318800 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318800&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374622 384222089 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622976 OC(=O)[C@H]1C[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC[C@H](C1)c1ccccc1 InChI=1S/C30H32N2O3/c33-29(28(23-13-6-2-7-14-23)24-15-8-3-9-16-24)32-21-26(19-27(32)30(34)35)31-18-10-17-25(20-31)22-11-4-1-5-12-22/h1-9,11-16,25-28H,10,17-21H2,(H,34,35) NLEUYIKWYGKLNG-UHFFFAOYSA-N 318824 US9624243, 52 Type-2 angiotensin II receptor Human 63.2 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318824 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318824&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374625 384222113 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622977 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)N1CCC2(C1)CCCON2Cc1ccccc1 InChI=1S/C33H37N3O4/c37-31(30(26-13-6-2-7-14-26)27-15-8-3-9-16-27)35-23-28(21-29(35)32(38)39)34-19-18-33(24-34)17-10-20-40-36(33)22-25-11-4-1-5-12-25/h1-9,11-16,28-30H,10,17-24H2,(H,38,39) XWODPWDIMHTKNK-UHFFFAOYSA-N 318801 US9624243, 115:: (2S,4S)-4-(6-benzyl-7-oxa-2,6-diazaspiro[4,5]decan-2-yl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 115 Type-2 angiotensin II receptor Human 321 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318801 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318801&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762174 384222090 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622978 CN(CC#Cc1ccccc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C29H28N2O3/c1-30(19-11-14-22-12-5-2-6-13-22)25-20-26(29(33)34)31(21-25)28(32)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,19-21H2,1H3,(H,33,34) SPTDDEMGVGOBAE-UHFFFAOYSA-N 318802 US9624243, 116:: (2S,4S)1-(2,2-diphenylacetyl)-4-(methyl(3-phenylprop-2-yn-1-yl)amino)pyrrolidine-2-carboxylic ::US10370388, Compound 116 Type-2 angiotensin II receptor Human 650 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318802 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318802&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622331 384222091 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622979 OC(=O)[C@@H]1C[C@H](CS(=O)(=O)Cc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C27H27NO5S/c29-26(25(22-12-6-2-7-13-22)23-14-8-3-9-15-23)28-17-21(16-24(28)27(30)31)19-34(32,33)18-20-10-4-1-5-11-20/h1-15,21,24-25H,16-19H2,(H,30,31) HJCIEOAWYBCWKI-UHFFFAOYSA-N 318803 US9624243, 118::(2S,4S)-4-((benzylsulfonyl)methyl)-1-(diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 118 Type-2 angiotensin II receptor Human 314 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318803 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318803&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677488 384222092 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622980 OC(=O)[C@@H]1C[C@H](CS(=O)(=O)c2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C26H25NO5S/c28-25(24(20-10-4-1-5-11-20)21-12-6-2-7-13-21)27-17-19(16-23(27)26(29)30)18-33(31,32)22-14-8-3-9-15-22/h1-15,19,23-24H,16-18H2,(H,29,30) KTWUBWHZDMVDKG-UHFFFAOYSA-N 318804 US9624243, 119::(2S,4S)-4-((phenylsulfonyl)methyl)-1-(diphenylacetyl)-pyrrolidine-2-carboxylic acid::US10370388, Compound 119 Type-2 angiotensin II receptor Human 2647 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318804 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318804&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681639 384222093 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622981 OC(=O)[C@@H]1C[C@H](CSCCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C28H29NO3S/c30-27(26(23-12-6-2-7-13-23)24-14-8-3-9-15-24)29-19-22(18-25(29)28(31)32)20-33-17-16-21-10-4-1-5-11-21/h1-15,22,25-26H,16-20H2,(H,31,32) KQMAXUKNLKOSCK-UHFFFAOYSA-N 318805 US9624243, 120::(2S,4S)-1-(2,2-diphenylacetyl)-4-((phenethylthio)methyl)pyrrolidine-2-carboxylic acid Type-2 angiotensin II receptor Human 1199 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318805 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318805&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622329 384222094 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622982 OC(=O)[C@@H]1C[C@H](CSCc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C27H27NO3S/c29-26(25(22-12-6-2-7-13-22)23-14-8-3-9-15-23)28-17-21(16-24(28)27(30)31)19-32-18-20-10-4-1-5-11-20/h1-15,21,24-25H,16-19H2,(H,30,31) CXXLZNHCGQJFBK-UHFFFAOYSA-N 318806 US9624243, 121::(2S,4S)-4-((benzylthio)methyl)-1-(2,2-diphenylacetyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 121 Type-2 angiotensin II receptor Human 57.7 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318806 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318806&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622327 384222095 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622983 OC(=O)[C@@H]1C[C@H](CSc2ccccc2)CN1C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C26H25NO3S/c28-25(24(20-10-4-1-5-11-20)21-12-6-2-7-13-21)27-17-19(16-23(27)26(29)30)18-31-22-14-8-3-9-15-22/h1-15,19,23-24H,16-18H2,(H,29,30) FFTNAJKBQGJZOH-UHFFFAOYSA-N 318807 US9624243, 122::(2S,4S)-1-(2,2-diphenylacetyl)-4-((phenylthio)methyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 122 Type-2 angiotensin II receptor Human 143 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318807 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318807&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622326 384222096 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622984 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCCc1ccccc1 InChI=1S/C28H29NO3S/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)33-18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32) UAYMXVSZVUHHQJ-UHFFFAOYSA-N 318808 US9624243, 124::(2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl)thio)-pyrrolidine-2-carboxylic acid::US10370388, Compound 124 Type-2 angiotensin II receptor Human 363 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318808 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318808&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681558 384222097 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622985 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)S(=O)(=O)CCCc1ccccc1 InChI=1S/C28H29NO5S/c30-27(26(22-14-6-2-7-15-22)23-16-8-3-9-17-23)29-20-24(19-25(29)28(31)32)35(33,34)18-10-13-21-11-4-1-5-12-21/h1-9,11-12,14-17,24-26H,10,13,18-20H2,(H,31,32) SMQJHFDQORQADU-UHFFFAOYSA-N 318809 US9624243, 125:: (2S,4S)-1-(2,2-diphenylacetyl)-4-((3-phenylpropyl)-sulfonyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 125 Type-2 angiotensin II receptor Human 1244 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318809 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318809&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622330 384222098 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622986 CN(CCOc1ccccc1F)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(O)=O InChI=1S/C28H29FN2O4/c1-30(16-17-35-25-15-9-8-14-23(25)29)22-18-24(28(33)34)31(19-22)27(32)26(20-10-4-2-5-11-20)21-12-6-3-7-13-21/h2-15,22,24,26H,16-19H2,1H3,(H,33,34) XZGFVHNFFXJNTG-UHFFFAOYSA-N 318810 US9624243, 126::(2S,4S)-1-(2,2-diphenylacetyl)-4-((2-fluorophenoxy)ethyl)(methyl)amino)pyrrolidine-2-carboxylic acid::US10370388, Compound 126 Type-2 angiotensin II receptor Human 20.5 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318810 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318810&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374623 384222099 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622987 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCc1ccccc1 InChI=1S/C27H27NO3S/c29-26(25(21-12-6-2-7-13-21)22-14-8-3-9-15-22)28-19-23(18-24(28)27(30)31)32-17-16-20-10-4-1-5-11-20/h1-15,23-25H,16-19H2,(H,30,31) DBXYGTHVEKXVAM-UHFFFAOYSA-N 318811 US9624243, 131::(2S,4S)-1-(2,2-diphenylacetyl)-4-(phenethylthio)pyrrolidine-2-carboxylic acid::US10370388, Compound 131 Type-2 angiotensin II receptor Human 652 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318811 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318811&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622193 384222100 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622988 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)SCCCc1ccc(F)cc1 InChI=1S/C28H28FNO3S/c29-23-15-13-20(14-16-23)8-7-17-34-24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33) YANZCJOFCAZZGC-UHFFFAOYSA-N 318812 US9624243, 133::(2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluorophenyl)propyl)thio)pyrrolidine-2-carboxylic acid::US10370388, Compound 133 Type-2 angiotensin II receptor Human 1738 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318812 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318812&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681513 384222101 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622989 OC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)S(=O)(=O)CCCc1ccc(F)cc1 InChI=1S/C28H28FNO5S/c29-23-15-13-20(14-16-23)8-7-17-36(34,35)24-18-25(28(32)33)30(19-24)27(31)26(21-9-3-1-4-10-21)22-11-5-2-6-12-22/h1-6,9-16,24-26H,7-8,17-19H2,(H,32,33) DGHBMICUFYBOQO-UHFFFAOYSA-N 318813 US9624243, 134::(2S,4S)-1-(2,2-diphenylacetyl)-4((3-(4-fluorophenyl)propyl)sulfonyl)pyrrolidine-2-carboxylic acid::US10370388, Compound 134 Type-2 angiotensin II receptor Human 954 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318813 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318813&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622194 384222102 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622990 CS(=O)(=O)NC(=O)[C@@H]1C[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C29H32N2O5S/c1-37(34,35)30-28(32)26-20-25(36-19-11-14-22-12-5-2-6-13-22)21-31(26)29(33)27(23-15-7-3-8-16-23)24-17-9-4-10-18-24/h2-10,12-13,15-18,25-27H,11,14,19-21H2,1H3,(H,30,32) TXIUZQBNSNMVAH-UHFFFAOYSA-N 318814 US9624243, 135::(2S,4S)-1-(2,2-diphenylacetyl)-N-(methylsulfonyl)-4-(phenylpropoxy)pyrrolidine-2-carboxamide::US10370388, Compound 135 Type-2 angiotensin II receptor Human 240 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318814 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318814&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 117762409 384222103 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622991 CN(CCCc1ccc(F)cc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)C(N)=O InChI=1S/C29H32FN3O2/c1-32(18-8-9-21-14-16-24(30)17-15-21)25-19-26(28(31)34)33(20-25)29(35)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H2,31,34) KPZRZJUXBNKMTI-UHFFFAOYSA-N 318815 US9624243, 136::(2S,4S)-1-(2,2-diphenylacetyl)-44(3-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carboxamide::US10370388, Compound 136 Type-2 angiotensin II receptor Human 89.0 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318815 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318815&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622057 384222104 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622992 CN(CCCc1ccc(F)cc1)[C@H]1C[C@@H](C#N)N(C1)C(=O)C(c1ccccc1)c1ccccc1 InChI=1S/C29H30FN3O/c1-32(18-8-9-22-14-16-25(30)17-15-22)27-19-26(20-31)33(21-27)29(34)28(23-10-4-2-5-11-23)24-12-6-3-7-13-24/h2-7,10-17,26-28H,8-9,18-19,21H2,1H3 CIYODQRQZJRWKS-UHFFFAOYSA-N 318816 US9624243, 137::(2S,4S)-1-(2,2diphenylacetyl)-4˜03-(4-fluorophenyl)propyl)(methyl)amino)pyrrolidine-2-carbonitrile::US10370388, Compound 137 Type-2 angiotensin II receptor Human 173 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318816 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318816&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 71622192 384222105 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622993 CN(CCCc1ccc(F)cc1)[C@H]1C[C@H](N(C1)C(=O)C(c1ccccc1)c1ccccc1)c1nnn[nH]1 |r| InChI=1S/C29H31FN6O/c1-35(18-8-9-21-14-16-24(30)17-15-21)25-19-26(28-31-33-34-32-28)36(20-25)29(37)27(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-7,10-17,25-27H,8-9,18-20H2,1H3,(H,31,32,33,34) KNRLDBXQDSZTRX-UHFFFAOYSA-N 318817 US9624243, 138::1-(2S,4S)-44(3-(4-fluorophenyl)propyl)(methyl)amino)-2-(1H-tetrazol-5-yl)pyrrolidin-1-yl)-2,2-diphenylethanoate Type-2 angiotensin II receptor Human 3.52 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318817 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318817&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 138374624 384222106 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622994 OC(=O)[C@@H]1C=C(CN1C(=O)C(c1ccccc1)c1ccccc1)c1sccc1-c1ccccc1 |c:4| InChI=1S/C29H23NO3S/c31-28(26(21-12-6-2-7-13-21)22-14-8-3-9-15-22)30-19-23(18-25(30)29(32)33)27-24(16-17-34-27)20-10-4-1-5-11-20/h1-18,25-26H,19H2,(H,32,33) OERKEVDGARSKPT-UHFFFAOYSA-N 318818 US9624243, 139:: (S)-1-(2,2-diphenylacetyl)-4-(3-phenylthiophen-2-yl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid::US10370388, Compound 139 Type-2 angiotensin II receptor Human 2533 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318818 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318818&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89681504 384222107 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622995 OC(=O)[C@@H]1C=C(CN1C(=O)C(c1ccccc1)c1ccccc1)C#CCCc1ccccc1 |c:4| InChI=1S/C29H25NO3/c31-28(27(24-16-6-2-7-17-24)25-18-8-3-9-19-25)30-21-23(20-26(30)29(32)33)15-11-10-14-22-12-4-1-5-13-22/h1-9,12-13,16-20,26-27H,10,14,21H2,(H,32,33) CNHMBDHFFFCFJM-UHFFFAOYSA-N 318819 US9624243, 140:: (S)-1-(2,2-diphenylacetyl)-4-(4-phenylbut-1-yn-1-yl)-2,5-dihydro-1H-pyrrole-2-carboxylic acid::US10370388, Compound 140 Type-2 angiotensin II receptor Human 674 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318819 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318819&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677697 384222108 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622996 OC(=O)[C@@H]1[C@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31) YVHCQCFELZHKAG-UHFFFAOYSA-N 318820 US9624243, 142:: (2S,3S)-1-(2,2-diphenylacetyl)-3-(3-phenylpropoxy)-azetidine-2-carboxylic acid::US10370388, Compound 142 Type-2 angiotensin II receptor Human 993 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318820 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318820&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677138 384222109 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622997 OC(=O)[C@H]1[C@@H](CN1C(=O)C(c1ccccc1)c1ccccc1)OCCCc1ccccc1 InChI=1S/C27H27NO4/c29-26(24(21-14-6-2-7-15-21)22-16-8-3-9-17-22)28-19-23(25(28)27(30)31)32-18-10-13-20-11-4-1-5-12-20/h1-9,11-12,14-17,23-25H,10,13,18-19H2,(H,30,31) YVHCQCFELZHKAG-UHFFFAOYSA-N 318821 US9624243, 143:: (2R,3R)-3-(3-phenylpropoxy)-1-(2,2-diphenylacetyl)-azetidine-2-carboxylic acid Type-2 angiotensin II receptor Human 372 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318821 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318821&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 89677758 384222110 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622998 CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1 InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) PSIFNNKUMBGKDQ-UHFFFAOYSA-N 318822 US9624243, Losartin::US10370388, Compound Losartin Type-2 angiotensin II receptor Human 11.0 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318822&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 3961 384222111 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 622999 CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1 InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) PSIFNNKUMBGKDQ-UHFFFAOYSA-N 318822 US9624243, Losartin::US10370388, Compound Losartin Type-2 angiotensin II receptor Human 5.50 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=318822 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=318822&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 3961 384222111 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 623000 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O |wU:4.4,47.47,60.63,35.36,20.21,wD:2.2,24.32,8.17,64.66,(24.13,1.24,;24.1,-.31,;25.42,-1.09,;26.77,-.35,;25.4,-2.63,;24.05,-3.38,;22.73,-2.59,;22.75,-1.05,;21.38,-3.34,;21.36,-4.88,;22.68,-5.66,;24.01,-4.93,;25.33,-5.71,;25.32,-7.24,;26.64,-8.05,;23.97,-8.01,;22.65,-7.22,;20.06,-2.55,;18.71,-3.29,;18.68,-4.83,;17.38,-2.5,;16.04,-3.25,;14.72,-2.46,;14.74,-.92,;13.37,-3.2,;13.34,-4.74,;14.66,-5.53,;14.64,-7.08,;15.96,-7.87,;15.93,-9.4,;14.59,-10.16,;17.25,-10.21,;12.05,-2.42,;10.69,-3.15,;10.67,-4.69,;9.37,-2.36,;8.03,-3.1,;9.4,-.82,;10.75,-.07,;12.07,-.88,;10.78,1.47,;17.41,-.96,;18.76,-.21,;16.1,-.17,;26.72,-3.43,;26.69,-4.97,;28.07,-2.68,;29.38,-3.48,;30.73,-2.73,;30.75,-1.19,;29.53,-.27,;30.03,1.18,;31.57,1.17,;32.02,-.31,;29.35,-5.02,;28.01,-5.76,;30.54,-5.79,;31.99,-5.25,;32.95,-6.46,;32.1,-7.74,;30.62,-7.33,;29.33,-8.36,;27.89,-7.82,;29.58,-9.88,;28.39,-10.86,;26.95,-10.32,;25.76,-11.3,;26.02,-12.81,;24.84,-13.79,;23.4,-13.26,;23.14,-11.74,;24.32,-10.75,;28.64,-12.38,;27.45,-13.36,;30.08,-12.92,)| InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55) CZGUSIXMZVURDU-UHFFFAOYSA-N 50236697 L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine::Ile(5)-angiotensin II::5-L-isoleucineangiotensin II::5-isoleucine-angiotensin II::Angiotensin II::Asp-Arg-Val-Tyr-Ile-His-Pro-Phe::N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine::angiotensin II (human)::angiotensin II (mouse)::human angiotensin II::isoleucine(5)-angiotensin II::CHEMBL408403::US9624243, Angiotensin II Type-2 angiotensin II receptor Human 1.80 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50236697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50236697&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172198 104056366 131170 CHEMBL408403 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7 623001 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O |wU:4.4,47.47,60.63,35.36,20.21,wD:2.2,24.32,8.17,64.66,(24.13,1.24,;24.1,-.31,;25.42,-1.09,;26.77,-.35,;25.4,-2.63,;24.05,-3.38,;22.73,-2.59,;22.75,-1.05,;21.38,-3.34,;21.36,-4.88,;22.68,-5.66,;24.01,-4.93,;25.33,-5.71,;25.32,-7.24,;26.64,-8.05,;23.97,-8.01,;22.65,-7.22,;20.06,-2.55,;18.71,-3.29,;18.68,-4.83,;17.38,-2.5,;16.04,-3.25,;14.72,-2.46,;14.74,-.92,;13.37,-3.2,;13.34,-4.74,;14.66,-5.53,;14.64,-7.08,;15.96,-7.87,;15.93,-9.4,;14.59,-10.16,;17.25,-10.21,;12.05,-2.42,;10.69,-3.15,;10.67,-4.69,;9.37,-2.36,;8.03,-3.1,;9.4,-.82,;10.75,-.07,;12.07,-.88,;10.78,1.47,;17.41,-.96,;18.76,-.21,;16.1,-.17,;26.72,-3.43,;26.69,-4.97,;28.07,-2.68,;29.38,-3.48,;30.73,-2.73,;30.75,-1.19,;29.53,-.27,;30.03,1.18,;31.57,1.17,;32.02,-.31,;29.35,-5.02,;28.01,-5.76,;30.54,-5.79,;31.99,-5.25,;32.95,-6.46,;32.1,-7.74,;30.62,-7.33,;29.33,-8.36,;27.89,-7.82,;29.58,-9.88,;28.39,-10.86,;26.95,-10.32,;25.76,-11.3,;26.02,-12.81,;24.84,-13.79,;23.4,-13.26,;23.14,-11.74,;24.32,-10.75,;28.64,-12.38,;27.45,-13.36,;30.08,-12.92,)| InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55) CZGUSIXMZVURDU-UHFFFAOYSA-N 50236697 L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine::Ile(5)-angiotensin II::5-L-isoleucineangiotensin II::5-isoleucine-angiotensin II::Angiotensin II::Asp-Arg-Val-Tyr-Ile-His-Pro-Phe::N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine::angiotensin II (human)::angiotensin II (mouse)::human angiotensin II::isoleucine(5)-angiotensin II::CHEMBL408403::US9624243, Angiotensin II Type-2 angiotensin II receptor Human 0.898 US Patent 10.7270/Q2J67K0B aid1796599 US9624243 McCarthy, TD; Naylor, A 4/18/2017 5/15/2019 Novartis http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50236697 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000277&target=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50236697&enzyme=Type-2+angiotensin+II+receptor&column=ki&startPg=0&Increment=50&submit=Search 172198 104056366 131170 CHEMBL408403 1 MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS Type-2 angiotensin II receptor AGTR2_HUMAN P50052 B2R9V1 Q13016 Q6FGY7